Merck and company's partner Ridgeback Biotherapeutics said its experimental antiviral drug molnupiravir could halve chances of dying or being hospitalised; Divi's Laboratories makes the main...
from NDTV Profit - Latest https://ift.tt/2ZKW4f2
via
No comments:
Post a Comment